Propanc Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Propanc Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Propanc Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 25, 2024 was 688M shares, a 4538% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 688M +673M +4538% Sep 25, 2024 10-K 2024-09-30
Q1 2024 52.1M -3.24B -98.4% Feb 20, 2024 10-Q 2024-02-20
Q3 2023 14.8M -662M -97.8% Sep 27, 2023 10-K 2023-09-28
Q1 2023 3.29B May 12, 2023 10-Q 2023-05-15
Q4 2022 1.76B +1.7B +2772% Feb 9, 2023 10-Q 2023-02-10
Q3 2022 677M +636M +1548% Sep 26, 2022 10-K 2022-09-28
Q2 2022 122M May 16, 2022 10-Q 2022-05-16
Q4 2021 61.4M +57.8M +1589% Feb 14, 2022 10-Q 2022-02-14
Q3 2021 41.1M -648M -94% Sep 24, 2021 10-K 2021-09-28
Q1 2021 5.97M -41.1M -87.3% May 14, 2021 10-Q 2021-05-14
Q4 2020 3.64M -1.55M -29.9% Feb 9, 2021 10-Q 2021-02-12
Q3 2020 689M +688M +58759% Sep 28, 2020 10-K 2020-10-01
Q1 2020 47.1M -374M -88.8% May 11, 2020 10-Q 2020-05-15
Q4 2019 5.19M -329M -98.4% Feb 13, 2020 10-Q 2020-02-14
Q3 2019 1.17M -161M -99.3% Oct 2, 2019 10-K 2019-10-15
Q1 2019 421M +382M +998% May 10, 2019 10-Q 2019-05-15
Q4 2018 334M +313M +1476% Feb 14, 2019 10-Q 2019-02-14
Q3 2018 162M +156M +2397% Sep 17, 2018 10-K 2018-09-17
Q1 2018 38.3M +34.6M +921% May 10, 2018 10-Q 2018-05-10
Q4 2017 21.2M -893M -97.7% Feb 8, 2018 10-Q 2018-02-09
Q3 2017 6.49M -783M -99.2% Sep 28, 2017 10-K 2017-09-28
Q1 2017 3.75M -718M -99.5% May 8, 2017 10-Q 2017-05-08
Q4 2016 914M +439M +92.3% Feb 14, 2017 10-Q 2017-02-14
Q3 2016 790M +433M +121% Sep 26, 2016 10-K 2016-09-28
Q1 2016 722M +530M +277% May 11, 2016 10-Q 2016-05-16
Q4 2015 476M +385M +423% Feb 9, 2016 10-Q 2016-02-16
Q3 2015 357M +274M +333% Sep 30, 2015 10-K 2015-09-30
Q1 2015 192M Feb 16, 2015 10-Q 2015-02-17
Q4 2014 91M +18.3M +25.1% Nov 19, 2014 10-Q 2014-11-19
Q3 2014 82.4M +11M +15.3% Oct 14, 2014 10-K 2014-10-14
Q2 2014 72.7M +2.05M +2.91% May 19, 2014 10-Q 2014-05-20
Q4 2013 72.7M -1.01M -1.37% Feb 10, 2014 10-Q 2014-02-14
Q3 2013 71.5M -1.53M -2.09% Oct 11, 2013 10-K 2013-10-15
Q2 2013 70.6M -2.15M -2.95% May 20, 2013 10-Q 2013-05-20
Q1 2013 73M +985K +1.37% Feb 19, 2013 10-Q 2013-02-20
Q4 2012 73.7M Nov 19, 2012 10-Q 2012-11-19
Q3 2012 73M Oct 11, 2012 10-K 2012-10-15
Q2 2012 72.8M May 18, 2012 10-Q 2012-05-21
Q1 2012 72M Feb 29, 2012 10-Q/A 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.